SCHEMBL30458942

SCHEMBL30458942

Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 17/20 0.63
ESR2 Q92731 5/20 0.63
MLNR O43193 1/20 0.63
NR1I2 O75469 1/20 0.63
NR3C1 P04150 1/20 0.63
CHRM2 P08172 1/20 0.63
ADRB1 P08588 1/20 0.63
ADRA2A P08913 1/20 0.63
ADORA3 P0DMS8 1/20 0.63
CHRM1 P11229 1/20 0.63
DRD2 P14416 1/20 0.63
ADRA2B P18089 1/20 0.63
ADRA2C P18825 1/20 0.63
CHRM3 P20309 1/20 0.63
SLC6A2 P23975 1/20 0.63
NPY1R P25929 1/20 0.63
HTR2A P28223 1/20 0.63
HTR2C P28335 1/20 0.63
AVPR2 P30518 1/20 0.63
SLC6A4 P31645 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4314882 0.97 ESR1 (0.64) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL27259212 0.92 ESR1 (0.59) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL23660874 0.92 ESR1 (0.59) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL26184181 0.92 ESR1 (0.59) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL25079599 0.89 ESR1 (0.62) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL13875376 0.88 ESR1 (0.58) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL26645551 0.88 ESR1 (0.56) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL25479881 0.88 ESR1 (0.59) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL31571975 0.87 ESR1 (0.55) ESR1ESR2MLNRNR1I2NR3C1
SCHEMBL30952384 0.87 ESR1 (0.55) ESR1ESR2MLNRNR1I2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 WO claimed
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 WO disclosed